Posted by Michael Wonder on 29 Feb 2020
Highlights from the 24-27 February 2020 CHMP meeting
28 February 2020 - Two new medicines recommended for approval
EMA’s CHMP recommended two medicines for approval at its February 2020 meeting.
The Committee recommended granting a marketing authorisation for Fetcroja (cefiderocol) for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options.
